Workflow
REGENXBIO(RGNX) - 2024 Q3 - Earnings Call Transcript
RGNXREGENXBIO(RGNX)2024-11-07 04:16

Call Start: 16:30 January 1, 0000 5:24 PM ET REGENXBIO Inc. (NASDAQ:RGNX) Q3 2024 Earnings Call November 6, 2024 16:30 ET Company Participants Patrick Christmas - Chief Legal Officer Curran Simpson - President and Chief Executive Officer Mitchell Chan - Chief Financial Officer Steve Pakola - Chief Medical Officer Conference Call Participants Gospel Enyindah-Asonye - Morgan Stanley Mani Foroohar - Leerink Partners Jack Padovano - Stifel Luca Issi - RBC Capital Markets Paul Choi - Goldman Sachs Daniil Gatauli ...